FDA Adverse Event Injury Summary report: N

TAPERLOC POR FMRL 13.5X147

MDR report key: 7633245 · Received June 25, 2018

Report

Report Number
0001825034-2018-04002
Event Type
Injury
Date Received
June 25, 2018
Date of Event
December 30, 2015
Report Date
June 27, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
LPH
PMA / PMN Number
PK030055
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: 11-173661, M2A 38MM MOD HD -3MM NK, 603760, 15-106056, M2A-38 CUP NON FLARED SZ 56MM, 952330. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. PRODUCT LOCATION UNKNOWN.

Additional Manufacturer Narrative · 1

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034-2018-04001; 0001825034-2018-04000. REPORTED EVENT WAS CONFIRMED BY REVIEW OF THE PROVIDED OP NOTES WHICH CONFIRMED THE PATIENT'S BLOOD LOSS. DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT EXPERIENCED A BLOOD LOSS OF 800 CC REQUIRING A TRANSFUSION. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
478011 TAPERLOC POR FMRL 13.5X147 PROSTHESIS, HIP LPH ZIMMER BIOMET, INC. N/A 109310

Patients

Seq Age Sex Outcome Treatment
1 92 YR Required Intervention